Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence

The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested." 16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to placebo or amantadine. Participants attend group meeting 3 times/week more

Medical trial

ClinicalTrials.gov Identifier:

NCT00000301

Sponsor:

National Institute on Drug Abuse

Design:

View entire collection »

Primary outcomes:

Cocaine craving
Cocaine use
Psychosocial progress
Retention

Start date:

Mar 1996

Phase:

Eligibile genders:

View entire collection »

Minimum age for eligibility:

Maximum age for eligibility:

Eligibility exclusion criteria:

Healthy

Location:

View entire collection »

top ↑

You can help improve this topic by adding more facts here

Edit this topic

Last edited Oct 30, 2009 See all topic history »

Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence – 4

Medical trial

ClinicalTrials.gov Identifier:

Sponsor:

Design:

Primary outcomes:

Start date:

Phase:

Eligibile genders:

Minimum age for eligibility:

Maximum age for eligibility:

Eligibility exclusion criteria:

Location:

Health authority:

References:

Diseases:

Treatment being tested:

What is Freebase?

Flag this Topic

Why do you want to flag this topic?

Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence – 4

Medical trial

ClinicalTrials.gov Identifier:

Sponsor:

Design:

Primary outcomes:

Start date:

Phase:

Eligibile genders:

Minimum age for eligibility:

Maximum age for eligibility:

Eligibility exclusion criteria:

Location:

Health authority:

References:

Diseases:

Treatment being tested:

Related Topics

What is Freebase?

Flag this Topic

Why do you want to flag this topic?